News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
Chameleon Biosciences, a Berkeley-based biotech aiming to enable safer and more effective gene therapies, has won the Immunomodulatory Solution of the Year in the Biotech Breakthrough Awards, run by the Tech Breakthrough organization.
One dose of an antibody drug protected from malaria infection during the malaria season in Mali, showing up to 88% effectiveness: demonstrating for the first time that a monoclonal antibody can prevent malaria in an endemic region.
Charles River Laboratories International has expanded its cell therapy contract development and manufacturing (CDMO) facility in Tennessee.
Texas based, iBio, is divesting its CDMO business and cGMP biologics manufacturing facility. It is also set to reduce its workforce by 60%.